Anthony D. Konkoly
Member
Practice Focus
Professional Experience
Tony has a broad range of experience with publicly held and large privately held businesses in both the law firm and corporate setting.
Before joining the firm, Tony spent eleven years as in-house counsel at Noveon, Inc. (formerly the specialty chemicals business segment of The B.F. Goodrich Company) and The B.F. Goodrich Company in a number of positions, most recently serving as Group Counsel to Noveon’s Performance Coatings Group. In this position, he was primary legal counsel to Noveon’s largest business unit and had additional responsibilities as primary legal counsel to Noveon’s corporate global purchasing, tax, and treasury functions. Tony began his legal career as an associate attorney with a big Cleveland, Ohio law firm where his practice focused on corporate and securities law.
Education
- Case Western Reserve University, Weatherhead School of Management (1996)
- Case Western Reserve University School of Law, J.D., magna cum laude (1986)
- University of Virginia - McIntire School of Commerce, B.S, with honors (1982)
State Admissions
Professional Associations
- Cleveland Metropolitan Bar Association
- Ohio State Bar Association
- American Corporate Counsel Association, member 1992-2002
Cases / Matters
- Represented large regional medical laboratory in sale of assets to publicly-traded laboratory company.
- Acted as primary venture counsel in establishment of clinical laboratory joint venture between regional hospital system and large multi-location clinic. Continues as primary corporate counsel to joint venture entity.
- Represented a number of pathologist-owned medical laboratories involved in merger, acquisition and joint venture activities.
- Represented Fortune 500 publicly-traded manufacturer in $27 million acquisition of division of privately-held manufacturing company.
- Represented U.S.-based logistics services company in establishment of joint venture in China.
- Represented Sri Lanka-based manufacturing company in establishment of strategic alliance with U.S.-based company.
- Served as interim general counsel of $1 billion sales manufacturing company, assisting client in negotiation of various commercial contracts, preparation of filings with Securities and Exchange Commission and other corporate matters.
- Represented retail/import-export company in sale of its wholesale division.
- Represented large chemical manufacturer in connection with conduct of its day-to-day operations, including negotiation and handling of all aspects of numerous acquisition and disposition transactions, establishment of joint ventures and strategic alliances, drafting and negotiation of commercial contracts of all types, and various legal compliance matters, including antitrust issues.
- Represented industrial water treatment service company in connection with negotiation and establishment of over $150 million worth of long-term commercial contracts with major customers in utility, chemical, oil and semiconductor industries.
- Represented industrial water treatment service company in connection with establishment of joint venture to provide industrial water treatment services in Mexico, including investigation of opportunity, structuring of joint venture, drafting and negotiation of contracts, and establishment of two business entities.
- Represented regional telephone company in establishment of numerous joint ventures in the cellular telephone business and in connection with several acquisition transactions.
- Counseled several publicly held companies in connection with establishment and use of hostile takeover defenses.
Publications
- "Northeast Ohio's Global Challenge," Cleveland Bar Journal, April 2007
- "International Alliances Offer Opportunities to Spur Growth," Smart Business Cleveland, June 2005
Presentations
- "Key Legal and Business Issues with Laboratory Joint Ventures," Executive War College, April 2009.
- "Legal Aspects and Nuts and Bolts of the M&A Transaction," Executive War College, May 2008.
- "Mergers and Acquisitions in the Laboratory Industry," given at G-2 Medical Laboratory Industry Conference, October 2007.